Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA clears Mazor's combined spinal surgery system

This article was originally published in Clinica

Executive Summary

The US FDA has granted 510(k) clearance for Mazor Surgical Technologies' combined spinal surgical system, comprised of the firm's SpineAssist and C-Insight devices. The former is a miniature robotic navigation system to help surgeons accurately place spinal implants, while the latter is an interoperative 3D imaging system. The Israeli firm believes that the combined system will have added value over the two individual devices, as it will enable imaging during surgery without having to move the patient into a separate CT scanning room. Mazor plans to launch the combined product in the US in early 2011, and hopes it will boost sales and support higher prices. Both devices were already individually approved by the FDA.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT095618

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel